FOXOOTCServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as FOXOW
FOXO TECHNOLOGIES INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.10−0.01 (-9.09%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
FOXO TECHNOLOGIES INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Cares [Member] | $16.98M | $17.72M | $16.09M | $14.69M | $12.37M | $7.18M | $4.02M | – | – | – | – | 95.1% | +37.3% |
| Life Science Services [Member] | $852.21K | – | $252.50K | – | – | – | – | – | – | – | – | 4.8% | – |
| Labs and Life [Member] | – | – | – | – | – | $34.13K | $32.64K | $133.47K | $135.47K | $139.47K | $145.29K | – | – |
| Labs [Member] | – | – | – | $33.97K | $34.48K | $33.95K | $32.64K | – | – | – | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Foxo Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.